[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
袁靖. 郭海燕超声造影对宫颈癌不同分期的诊断价值[J]. 实用癌症杂志, 2019, 34(12): 2055-2058.
|
[3]
|
陈志, 鲍刚, 吴沁航, 等. 雷公藤甲素诱导结肠癌细胞凋亡的分子机制研究[J]. 时珍国医国药, 2019, 30(10): 2365-2367.
|
[4]
|
Zhu, R.X., et al. (2019) Growth Arrest-Specific Gene 2 Suppresses Hepatocarcinogenesis by Intervention of Cell Cycle and p53-Dependent Apoptosis. World Journal of Gastroenterology, 25, 4715-4726.
https://doi.org/10.3748/wjg.v25.i32.4715
|
[5]
|
翟士嘉, 侯博儒. 细胞周期蛋白依赖性激酶及其抑制剂在胶质母细胞瘤治疗中的研究进展[J]. 中华神经外科杂志, 2023, 39(2): 205-209.
|
[6]
|
Evans, T., Rosenthal, E.T., Youngblom, J., et al. (1983) Cyclin: A Protein Specified by Maternal mRNA in Sea Urchin Eggs That Is Destroyed at Each Cleavage Division. Cell, 33, 389-396. https://doi.org/10.1016/0092-8674(83)90420-8
|
[7]
|
Albero, R., Enjuanes, A., Demajo, S., et al. (2018) Cyclin D1 Overexpression Induces Global Transcriptional Downregulation in Lymphoid Neoplasms. Journal of Clinical Investigation, 128, 4132-4147.
https://doi.org/10.1172/JCI96520
|
[8]
|
Desantis, C.E., Miller, K.D., Sauer, A.G., et al. (2019) Cancer Statistics for African Americans, 2019. CA: A Cancer Journal for Clinicians, 69, 211-233. https://doi.org/10.3322/caac.21555
|
[9]
|
赵文文, 朱婧颖, 韩颖颖. CCND基因家族成员分子进化分析[J]. 医学分子生物学杂志, 2014(3): 144-149.
|
[10]
|
Gao, X., Leone, G.W. and Wang, H. (2020) Cyclin D-CDK4/6 Functions in Cancer. Advances in Cancer Research, 148, 147-169. https://doi.org/10.1016/bs.acr.2020.02.002
|
[11]
|
Harbour, J.W. and Dean, D.C. (2000) The Rb/E2F Pathway: Expanding Roles and Emerging Paradigms. Genes & Development, 14, 2393-2409. https://doi.org/10.1101/gad.813200
|
[12]
|
Xia, W., Lo, C.M., Poon, R.Y.C., et al. (2017) Smad In-hibitor Induces CSC Differentiation for Effective Chemosensitization in Cyclin D1- and TGF-beta/Smad-Regulated Liver Cancer Stem Cell-Like Cells. Oncotarget, 8, 38811-38824.
https://doi.org/10.18632/oncotarget.16402
|
[13]
|
Schwartz, M.D., Linzer, M., Babbott, D., et al. (1995) The Impact of an Ambulatory Rotation on Medical Student Interest in Internal Medicine. The Society of General Internal Medicine Task Force on Career Choice in Internal Medicine. Journal of General Internal Medicine, 10, 542-549. https://doi.org/10.1007/BF02640362
|
[14]
|
Quelle, D.E., Ashmun, R.A., Shurtleff, S.A., et al. (1993) Overexpres-sion of Mouse D-Type Cyclins Accelerates G1 Phase in Rodent Fibroblasts. Genes & Development, 7, 1559-1571. https://doi.org/10.1101/gad.7.8.1559
|
[15]
|
Baldin, V., Lukas, J., Marcote, M.J., et al. (1993) Cyclin D1 Is a Nuclear Protein Required for Cell Cycle Progression in G1. Genes & Development, 7, 812-821. https://doi.org/10.1101/gad.7.5.812
|
[16]
|
Nishida, N., Fukuda, Y., Komeda, T., et al. (1994) Amplification and Overexpression of the Cyclin D1 Gene in Aggressive Human Hepatocellular Carcinoma. Cancer Research, 54, 3107-3110.
|
[17]
|
Nikaido, T., Li, S.F., Shiozawa, T., et al. (1996) Coabnormal Expression of Cyclin D1 and p53 Protein in Human Uterine Endometrial Carcinomas. Cancer, 78, 1248-1253.
https://doi.org/10.1002/(SICI)1097-0142(19960915)78:6<1248::AID-CNCR12>3.0.CO;2-0
|
[18]
|
Wu, X., Zeng, Y., Wu, S., et al. (2015) MiR-204, Down-Regulated in Retinoblastoma, Regulates Proliferation and Invasion of Human Retinoblastoma Cells by Targeting CyclinD2 and MMP-9. FEBS Letters, 589, 645-650.
https://doi.org/10.1016/j.febslet.2015.01.030
|
[19]
|
Fatrai, S., Elghazi, L., Balcazar, N., et al. (2006) Akt Induces Beta-Cell Proliferation by Regulating Cyclin D1, Cyclin D2, and p21 Levels and Cyclin-Dependent Kinase-4 Activity. Diabetes, 55, 318-325.
https://doi.org/10.2337/diabetes.55.02.06.db05-0757
|
[20]
|
Evron, E., Umbricht, C.B., Korz, D., et al. (2001) Loss of Cyclin D2 Expression in the Majority of Breast Cancers Is Associated with Promoter Hypermethylation. Cancer Re-search, 61, 2782-2787.
|
[21]
|
叶静, 李明华, 龙霞, 等. 乳腺癌MCF-7细胞的分子生物学特征[J]. 实用癌症杂志, 2012, 27(2): 116-119.
|
[22]
|
Henrique, R., Costa, V.L., Cerveira, N., et al. (2006) Hypermethylation of Cyclin D2 Is Associated with Loss of mRNA Expression and Tumor Development in Prostate Cancer. Journal of Molecular Medicine (Berl), 84, 911-918.
https://doi.org/10.1007/s00109-006-0099-4
|
[23]
|
Bartkova, J., Lukas, J., Strauss, M., et al. (1998) Cyclin D3: Re-quirement for G1/S Transition and High Abundance in Quiescent Tissues Suggest a Dual Role in Proliferation and Dif-ferentiation. Oncogene, 17, 1027-1037.
https://doi.org/10.1038/sj.onc.1202016
|
[24]
|
Shaughnessy, J., Gabrea, A., Qi, Y., et al. (2001) Cyclin D3 at 6p21 Is Dysregulated by Recurrent Chromosomal Translocations to Immunoglobulin Loci in Multiple Myeloma. Blood, 98, 217-223.
https://doi.org/10.1182/blood.V98.1.217
|
[25]
|
Ma, Y., Yuan, J., Huang, M., et al. (2003) Regulation of the Cyclin D3 Promoter by E2F1. Journal of Biological Chemistry, 278, 16770-16776. https://doi.org/10.1074/jbc.M212702200
|
[26]
|
Filipits, M., Jaeger, U., Pohl, G., et al. (2002) Cyclin D3 Is a Predic-tive and Prognostic Factor in Diffuse Large B-Cell Lymphoma. Clinical Cancer Research, 8, 729-733.
|
[27]
|
王文虎, 曹秀芳. 宫颈癌组织中NF-κB、cyclinD1的表达及意义[J]. 山东医药, 2008(15): 90-91.
|
[28]
|
钱秀艳, 张淑兰. CCND1基因不同转录本在宫颈癌组织中的表达及意义[J]. 中国医科大学学报, 2010, 39(7): 508-510.
|
[29]
|
郑懿, 李希聪, 赵太坤, 等. 沉默CCND1基因表达抑制ERK/MAPK信号通路激活提升宫颈癌化疗敏感性[J]. 实用癌症杂志, 2021, 36(3): 354-359.
|
[30]
|
邹冬玲, 王冬, 周琦微. RNA-29b通过调控cyclin D2表达参与宫颈癌发生的机制研究[J]. 肿瘤, 2014, 34(12): 1090-1096.
|
[31]
|
沈树娜, 王辉, 宫本丽. miRNA29靶基因CCND2和CDK6在宫颈癌中的表达研究[J]. 中国妇幼健康研究, 2018, 29(1): 56-58.
|
[32]
|
刘秋利, 李婧, 李娟, 等. 阿帕替尼对宫颈癌细胞增殖及化疗敏感性的影响[J]. 现代妇产科进展, 2017, 26(11): 806-809.
|
[33]
|
潘剑锋, 尚方正, 马荣, 等. 周期蛋白和周期蛋白依赖性激酶及相关激酶抑制剂在细胞周期进程中的调控机制研究进展[J]. 生物工程学报, 2023, 39(4): 1525-1547.
|
[34]
|
何淑蓉, 刘龙腾, 陈荣明, 等. 细胞核形态评分联合细胞周期蛋白D1表达对术前甲状腺细针穿刺不确定性滤泡上皮病变诊断的研究[J]. 中华病理学杂志, 2023, 52(7): 696-701.
|